Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017 - MarketsandMarkets

Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017

Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017 - MarketsandMarkets
Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017
Published Jan 14, 2013
195 pages — Published Jan 14, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

This market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Scope of the Report

The research report categorizes this market into procedure, application, technology, product type and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the apheresis market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Global Market segmentation:

By Procedure:
Donor Apheresis
Therapeutic Apheresis
Neurologic Disorders
Blood Disorders (TTP, Leukemia, & Others)
Renal Disease
Metabolic Disorders
Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)

By Application:
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukoreduction/leukapheresis
Others (photopheresis, lipidpheresis, and Immunoadsoption)

By Technology:
Centrifugation
Membrane Separation/Filtration

By Product type:
Devices
Disposables

By End-user:
Blood banks/Blood collection centers
Hospitals & Hospital attached blood banks
Others

By Geography:
North America
Europe
Asia
RoW (Rest of the World)

Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.

  
Source:
Document ID
MD 1407
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 BLOOD SHORTAGE & BLOOD SAFETY TO INCREASE THE DEMAND FOR APHERESIS BLOOD
3.3.1.2 ADVANTAGE OF APHERESIS COLLECTION OVER WHOLE BLOOD COLLECTION TO BOOST THE GROWTH
3.3.1.3 INCREASING DEMAND FOR PLASMA DERIVED PRODUCTS TO SPUR THE APHERESIS MARKET
3.3.1.4 INCREASE IN AGING POPULATION DEMANDS GROWTH OF APHERESIS
3.3.2 RESTRAINTS
3.3.2.1 LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT THE GROWTH OF APHERESIS
3.3.2.2 HIGH COST OF APHERESIS PROCEDURES TO HINDER THE ACCEPTABILITY
3.3.3 OPPORTUNITIES
3.3.3.1 EXTENDING REACH OF APHERESIS
3.3.3.2 UNTAPPED PEDIATRIC SEGMENT CAN SOON GAIN IMPORTANCE IN APHERESIS
3.4 MARKET SHARE ANALYSIS
3.5 END-USER ANALYSIS

4 GLOBAL MARKET, BY PROCEDURE
4.1 INTRODUCTION
4.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS)
4.3 THERAPEUTIC APHERESIS
4.3.1 NEUROLOGIC DISORDERS
4.3.2 BLOOD DISORDERS
4.3.3 RENAL DISORDERS
4.3.4 METABOLIC DISORDERS
4.3.5 OTHER DISORDERS

5 GLOBAL MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.2 DEVICES
5.3 DISPOSABLES

6 GLOBAL MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 CENTRIFUGATION
6.2.1 DRIVER & RESTRAINT
6.2.1.1 ADVANTAGES OFFERED BY CENTRIFUGATION TECHNOLOGY OVER MEMBRANE SEPARATION
6.2.1.2 CENTRIFUGATION APHERESIS PROCESS IS TIME-CONSUMING
6.3 MEMBRANE SEPARATION

7 GLOBAL MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PLASMAPHERESIS
7.2.1 DRIVERS
7.2.1.1 HUGE DEMAND FOR PLASMA FROM BIOPHARMACEUTICAL COMPANIES
7.2.1.2 NEW APPLICATIONS AND OPPORTUNITIES IN DEVELOPING COUNTRIES
7.3 PLATELETPHERESIS
7.4 ERYTHROCYTAPHERESIS
7.5 LEUKAPHERESIS
7.6 OTHERS

8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW (REST OF THE WORLD)

9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 127
9.4 PRODUCTS LAUNCH
9.5 EXPANSIONS
9.6 OTHER DEVELOPMENTS
9.7 APPROVALS

10 COMPANY PROFILES(OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
10.1 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF
10.2 B. BRAUN MELSUNGEN AG
10.3 CERUS CORPORATION
10.4 FENWAL, INC.
10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA
10.6 HAEMONETICS CORPORATION
10.7 HEMACARE CORPORATION
10.8 KANEKA CORPORATION
10.9 KAWASUMI LABORATORIES, INC.
10.1 MEDICA S.P.A
10.11 NIKKISO CO., LTD.
10.12 TERUMO BCT, INC.
10.13 THERAKOS, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, & DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017" Jan 14, 2013. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Apheresis-Market-Therapeutic-Donor-Apheresis-Automated-Blood-Component-Collection-Applications-Plasmapheresis-Plateletpheresis-RBC-Erythrocytapheresis-Leukapheresis-Photopheresis-Devices-Disposables-Forecasts-To-2017-2144-25>
  
APA:
MarketsandMarkets. (2013). Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017 Jan 14, 2013. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Apheresis-Market-Therapeutic-Donor-Apheresis-Automated-Blood-Component-Collection-Applications-Plasmapheresis-Plateletpheresis-RBC-Erythrocytapheresis-Leukapheresis-Photopheresis-Devices-Disposables-Forecasts-To-2017-2144-25>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.